Regarding Fabp4 (FC = 2.85), recent studies have shown that it is increased in chronic inflammatory diseases such as osteoarthritis and in cellular models of inflammation, which have shown that its knockdown can suppress inflammation and oxidative stress by inhibiting the NF-κB signaling pathway [44]. Here, NFKB1 is linked to osteoarthritis.